Survey questions
’
The 14-item Healthcare Provider Growth Hormone Treatment Experience Survey consists of four distinct parts. The first part includes five items that ask physicians to compare both injection regimens and rate, using a five-point Likert scale, the time and effort required to: (1) explain the device’s instructions for use (IFU), (2) explain the injection regimen, (3) explain what to do if an injection is missed, (4) address patients’ and caregivers’ concerns, and (5) monitor treatment adherence.The second part of the survey comprises a set of three items that assess physicians’ preference for once-weekly somatrogon or once-daily rhGH in terms of general preference, convenience, and burden. The third part of the survey assesses physicians’ overall treatment preference for once-weekly somatrogon or once-daily rhGH using four items. The first item asks the physician to choose the injection regimen that the physician would be more likely to prescribe in the future. The remaining three items assess the physician’s perspective on which of the two injection regimens is more likely to be beneficial to patients, support positive long-term outcomes, and reduce healthcare utilization. For the second and third parts of this survey, physicians are asked to choose between the two injection regimens or select “No difference”. Each of the seven items in the second and third parts of the survey also includes an open-ended, free-text field in which physicians can describe the rationale for their selected response.The last part of the survey contains two items that assess physicians’ satisfaction with each injection regimen using a five-point Likert scale, ranging from “Very satisfied” to “Very dissatisfied”. The complete survey questionnaire is provided in the online 